These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37584613)

  • 1. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
    Ai W; Liu T; Lv C; Feng X; Wang Q
    Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
    Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
    Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers.
    Gu Y; Chen Q; Yin H; Zeng M; Gao S; Wang X
    Crit Rev Oncol Hematol; 2024 Jan; 193():104226. PubMed ID: 38056580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
    Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
    J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.
    Ji X; Zhu X; Lu X
    Future Oncol; 2017 Jul; 13(17):1537-1550. PubMed ID: 28685611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic Polymer-Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response.
    Zhang Y; Fang Z; Pan D; Li Y; Zhou J; Chen H; Li Z; Zhu M; Li C; Qin L; Ren X; Gong Q; Luo K
    Adv Mater; 2024 Jun; 36(25):e2401304. PubMed ID: 38469918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.
    Wang M; Xue W; Yuan H; Wang Z; Yu L
    Int J Nanomedicine; 2024; 19():2823-2849. PubMed ID: 38525013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers.
    Pei L; Liu Y; Liu L; Gao S; Gao X; Feng Y; Sun Z; Zhang Y; Wang C
    Mol Cancer; 2023 Feb; 22(1):29. PubMed ID: 36759842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
    Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
    Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
    Lunina NA; Safina DR; Kostrov SV
    Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.